Cox John

Average Profitability
<0.0001%
Insider Buys Quantity
1
Insider Buys Sum
$264,304.00
Insider Sells Quantity
15
Insider Sells Sum
$19.68M

Insider Activity of Cox John

According to the SEC Form 4 filings, Cox John, being in a position of

  1. CEO & President at Dyne Therapeutics, Inc.,
    оver the last 12 months, has bought 8000 shares for $264,304, and sold 0 shares,
    over all time since 2024-09-04, has bought 8000 shares for $264,304, and sold 0 shares.

The largest purchase of all time was on 2024-09-04 and amounted to 8000 shares of Dyne Therapeutics, Inc. for $264,304.

The largest sale of all time was on 2015-03-25 and amounted to 24020 shares of Biogen Inc. for $10.79M.

Biography of Cox John

No biography is available at this moment.

2024-09-04PurchaseDyne Therapeutics, Inc.
DYN
CEO & President
8,000
0.0085%
$33.04$264,304-7.83%
2020-03-24SaleRepligen Corporation
RGEN
director
1,858
0.0036%
$96.72$179,706+60.76%
2020-03-18SaleRepligen Corporation
RGEN
director
26,736
0.0507%
$95.27$2.55M+56.42%
2020-03-04SaleRepligen Corporation
RGEN
director
10,000
0.019%
$93.39$933,900+57.14%
2020-02-24SaleRepligen Corporation
RGEN
director
4,455
0.0086%
$92.81$413,455+58.72%
2015-03-25SaleBiogen Inc.
BIIB
EVP Pharmaceutical Oper & Tech
24,020
0.0106%
$449.06$10.79M-30.68%
2011-11-01SaleBiogen Inc.
BIIB
EVP Pharmaceutical Oper & Tech
4,350
0.0015%
$93.62$407,247+14.93%
2011-04-21SaleBiogen Inc.
BIIB
EVP Pharmaceutical Oper & Tech
4,350
0.0013%
$72.87$316,985+8.23%
2011-04-13SaleBiogen Inc.
BIIB
EVP Pharmaceutical Oper & Tech
36,234
0.0148%
$80.00$2.9M+32.24%
2011-04-11SaleBiogen Inc.
BIIB
EVP Pharmaceutical Oper & Tech
6,900
0.0017%
$47.92$330,648+35.83%
2011-03-31SaleBiogen Inc.
BIIB
EVP Pharmaceutical Oper & Tech
2,840
0.0007%
$43.50$123,540+42.25%
2011-03-02SaleBiogen Inc.
BIIB
EVP Pharmaceutical Oper & Tech
4,041
0.0017%
$70.10$283,259+43.81%
2011-02-17SaleBiogen Inc.
BIIB
EVP Pharmaceutical Oper & Tech
1,843
0.0008%
$67.08$123,620+46.99%
2010-11-09SaleBiogen Inc.
BIIB
EVP Pharmaceutical Oper & Tech
773
0.0003%
$62.87$48,597+43.93%
2010-11-02SaleBiogen Inc.
BIIB
EVP Pharmaceutical Oper & Tech
765
0.0003%
$63.04$48,228+43.24%
2010-10-28SaleBiogen Inc.
BIIB
EVP Pharmaceutical Oper & Tech
6,900
0.0015%
$33.97$234,393+40.06%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.